Privi Speciality Chemicals Limited has announced strong financial performance for the fiscal year ended March 31, 2026. The company reported a net profit of ₹35,744.19 lakhs on a standalone basis. Reflecting its solid performance, the Board of Directors has recommended a final dividend of ₹10 per share (100%). Additionally, the company confirmed key leadership re-appointments and scheduled its 41st Annual General Meeting for August 7, 2026.
FY26 Financial Performance
Privi Speciality Chemicals has delivered a strong set of results for the full financial year ended March 31, 2026. On a standalone basis, the company achieved total income of ₹2,47,241.86 lakhs, with a net profit for the year reaching ₹35,744.19 lakhs. Consolidated performance was equally impressive, with total income at ₹2,58,292.10 lakhs and net profit attributable to owners of the company at ₹32,753.73 lakhs.
Dividend and Shareholder Meetings
In recognition of the positive financial trajectory, the Board of Directors has recommended a final dividend of ₹10 per equity share (representing 100% of the face value of ₹10). This payout is subject to the approval of shareholders at the company’s 41st Annual General Meeting, which is scheduled to take place on August 7, 2026. The record date to determine shareholder entitlement for the dividend is set for July 31, 2026.
Strategic Leadership Updates
The Board has approved the re-appointment of Mr. Bhaktavatsala Rao Doppalapudi as an Executive Director (Whole-time Director) for a period of three years, effective from August 13, 2026, to August 12, 2029. Furthermore, the company has renewed its engagement with M/s. Aneja Associates as Internal Auditors and M/s. Kishore Bhatia & Associates as Cost Auditors for the 2026-27 financial year, ensuring continued operational oversight.
Source: BSE
